March 27, 2019
فارسی English русский
منطقه آزاد تجاری صنعتی انزلی
Production of raw materials for MS and blood coagulation for export to the Caspian littoral countries and supplying domestic needs

Dr. Amir Ebrahimi, vice- president of Arman Caspian Company, said: by   production of raw materials for MS and blood coagulation in the company, which is taking place for the first time in the Middle East, In addition to providing domestic need and prepare bases for exports to the countries of the Caspian Sea, especially Russia.

He stated that this company in addition to 15-year background in Pharmaceuticals, he previously worked at incubation center of Tehran University of Medical Sciences in the field of producing similar drugs, and the reason for choosing Anzali free zone for productive activities is to take advantage of its legal privileges and possible presence in the Caspian Sea market, especially in Russia, as well as the presence of educated and specialist youth in Guilan province. In the meantime, he emphasized on support of the Anzali Free Zone Organization in creating the necessary infrastructure for investing in this strategic area.

Dr. Ebrahimi, referring to the fact that we are currently in the process of installing and our production lines in the first phase of the project in the industrial states of Anzali Free Zone, so it will be ready to exploit this phase by two month later. For the first phase of this project, 100 billion riyals have been invested, and has created employment for 27 people.

The vice president of the Arman Caspian Company announced development process of this production unit is in three phases, In the second and third stages with Italian technology and the presence of Italian specialists variety of products will increase, During the five years of the implementation of the development plan, the production of the factory will be up to 2 thousand kilos.

It is noteworthy that the production of this type and this amount of raw material for the factories of the country is unique, because the production of these compounds in the Middle East will be monopolized by Iran, Currently, the total raw materials required by the pharmaceutical companies of the country are about 1,400 kg that is being imported from abroad.

Dr. Ebrahimi pointed to the use of specialist force in this manufacturing unit Drug Maker, Doctor and chemistry graduates are experts who work in this factory.

Anzali Free Zone Boulevard martyr fatehi phase of trade and tourism, free trade-industrial zone
Tel: 9813-34437671-3 Fax: 9813-34438006 P.O.Box: 43355-1145
Powered by DorsaPortal